Status: Phase 1
Entry Type: Small molecule
Molecule Category: UNKNOWN

Pharmacology

Primary Target
checkpoint kinase 1

Indications

Mesh Heading Maximum Phase Reference
Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin Phase 1 ClinicalTrials
Leukemia; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase 1 ClinicalTrials
CONTENTS